LATEST ALERTS
Regulation and legislation
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Anxiety disorder now a qualifying condition for medical cannabis prescriptions…
19th December 2022 - Alerts | New Mexico, North America, United States |
Italy: CBD and cannabis regulation, December 2022
19th December 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Advocates for psylocibin as therapeutic treatment push Canadian government
16th December 2022 - News analysis |
Canadian advocates for therapeutic access to psilocybin are ramping up their efforts to get the federal government to grant exemptions to the country’s drug laws so patients and healthcare providers can legally access the drug
Executives acquitted of fraud relating to cannabis production…
16th December 2022 - Alerts | Canada, North America |
Germany: CBD and cannabis snapshot
15th December 2022 - Market reports , Regulatory reports |
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Spain: CBD and cannabis snapshot
14th December 2022 - Market reports , Regulatory reports |
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Guidance issued on cannabis delivery…
12th December 2022 - Alerts | New York, North America, United States |
First legal recreational cannabis sales to begin in January…
12th December 2022 - Alerts | Connecticut, North America, United States |
Basel to begin recreational cannabis sales in January…
9th December 2022 - Alerts | Europe, Switzerland |
New US cannabis research law – ‘historic breakthrough’ or merely ‘a baby step’?
7th December 2022 - News analysis |
The Medical Marijuana and Cannabidiol Research Expansion Act, aimed at increasing research into the medical benefits of cannabis, has been signed into law by US president Joe Biden
State-controlled cannabis experiment postponed to 2024…
5th December 2022 - Alerts | Europe, Netherlands |
Medical cannabis bill passes the Senate…
5th December 2022 - Alerts | Michigan, North America, United States |
Governor signs industrial hemp bill into law…
5th December 2022 - Alerts | New York, North America, United States |
Medical Marijuana and Cannabidiol Research Expansion Act signed into law…
5th December 2022 - Alerts | North America, United States |
Global cannabinoid vape compliance guide
2nd December 2022 - Regulatory reports |
The cannabinoid vape compliance guide goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive
EKSN supports recreational cannabis legalisation…
2nd December 2022 - Alerts | Europe, Switzerland |
Bill introduced to establish advisory commission on cannabis regulation…
2nd December 2022 - Alerts | North America, United States |
Province lifts ban on some cannabis vapes…
2nd December 2022 - Alerts | Canada, North America |
South Korea: CBD and cannabis regulation, November 2022
30th November 2022 - Regulatory reports |
The South Korean legislation does not make a clear distinction between hemp and cannabis. This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas
Netherlands: CBD and cannabis snapshot
30th November 2022 - Market reports , Regulatory reports |
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
France: CBD and cannabis snapshot
29th November 2022 - Market reports , Regulatory reports |
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Grey area over medical cannabis regime in Mexico leaves industry pessimistic
28th November 2022 - News analysis |
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Clarification of rules for manufacturing medical cannabis products issued…
28th November 2022 - Alerts | Europe, United Kingdom |
Committee discusses future of cannabis-containing vapes…
28th November 2022 - Alerts | Chile, South America |
Panel members to review Cannabis Act announced…
28th November 2022 - Alerts | Canada, North America |
Future looks promising for US state-level legalisation despite midterm setback
25th November 2022 - News analysis |
It was a small setback for US pro-legalisation supporters, with only two of five state-level recreational cannabis measures on November midterm ballots being passed
Lebanon: CBD and cannabis regulation, November 2022
24th November 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
How will the midterm shift in the balance of power in Washington affect cannabis?
23rd November 2022 - News analysis |
The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power in Washington
European Court of Human Rights medical cannabis case result sets no precedent
21st November 2022 - News analysis |
A test case has demonstrated that the ECHR doesn’t consider access to cannabis to be a universal human right, and balancing a cannabis user’s human rights with public interest is best left to sovereign states
UK FSA novel food process can succeed with ‘supportive and sensible approach’
21st November 2022 - News analysis |
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
Board recommends tax changes for medical cannabis businesses…
21st November 2022 - Alerts | Iowa, North America, United States |
Biden to sign bill on medical cannabis and CBD research…
21st November 2022 - Alerts | North America, United States |
Government to set up new drug department…
21st November 2022 - Alerts | Colombia, South America |
